Company Encyclopedia
View More
name
Gerresheimer AG
GXI.DE
News
View More

Exane BNP Paribas downgrades Gerresheimer (0NTI) to a Sell

In a report released on December 10, from Exane BNP Paribas downgraded Gerresheimer to a Sell, with a price target of €22.00. The company’s shares closed yesterday at €25.50.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential Currently, the analyst consensus on Gerresheimer is a Hold with an average price target of €31.80.

Tip Ranks·
DE
GXI
0.00%
Tip Ranks·
DE
GXI
0.00%

‍Societe Generale SA​ Holds 5.07% Of Total Voting Rights And Instruments In Gerresheimer AG As Of Dec 1

GERRESHEIMER AG :SAYS ‍SOCIETE GENERALE SA​ HOLDS 5.07% OF TOTAL VOTING RIGHTS AND INSTRUMENTS IN GERRESHEIMER AG AS OF DEC 1 (PREVIOUSLY 0%) Source text for Workspace: Further company coverage:

Reuters·
DE
GXI
0.00%
US
SCGLY
+0.93%
Reuters·
DE
GXI
0.00%
US
SCGLY
+0.93%

BNP picks medtech favourites, sees re-rating in H2 2026

BNP Paribas sees a re-rating for European medtech stocks in H2 2026, despite 2025 challenges. Top picks include Essilorluxottica, Sartorius Stedim, and Fresenius. Straumann upgraded to "outperform" due to sales recovery and low valuation. Sartorius upgraded to "outperform" on improving equipment trends. Siemens Healthineers downgraded to "neutral" due to parent firm's overhang. Gerresheimer downgraded to "underperform" due to weakening markets and high leverage.

Reuters·
DE
GXI
0.00%
Reuters·
DE
GXI
0.00%

Gerresheimer falls after Morpheus reveals short position

** Shares in Gerresheimer are down around 2% after Morpheus Research said it holds a short position in it of around 0.5% of issued share capital** The shares dropped as much as 9.5% earlier in the session** Morpheus cites "risks to growth" related to Gerresheimer's flagship CagriSema contract and some issues connected to the Bormioli acquisition in May 2024 and the German group's attempt to divest its molded glass business** Gerresheimer says it will analyse the shortseller's claims and provide a statement as soon as possible

Reuters·
DE
GXI
0.00%
Reuters·
DE
GXI
0.00%

Berenberg Bank Keeps Their Hold Rating on Gerresheimer (0NTI)

Berenberg Bank analyst Christian Ehmann maintained a Hold rating on Gerresheimer, setting a price target of €30.00. The analyst consensus is a Hold with an average price target of €32.69. Ehmann has an average return of -4.8% and a 39.86% success rate.

Tip Ranks·
DE
GXI
0.00%
Tip Ranks·
DE
GXI
0.00%
© 2025 Longbridge｜Disclaimer